Einstein, Mark H <br/><br/>
Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma.  [electronic resource] 

 -  Gynecologic oncology  Jan 2012 
 - 21-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2011.10.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Brachytherapy<br/>Carboplatin--administration & dosage<br/>Carcinoma, Papillary--drug therapy<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Dose Fractionation, Radiation<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage<br/>Radiotherapy, Adjuvant--adverse effects<br/>Uterine Neoplasms--drug therapy